These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2283897)

  • 21. Production and regulation of tumor necrosis factor alpha. A cellular and molecular analysis.
    Kunkel SL; Spengler M; Kwon G; May MA; Remick DG
    Methods Achiev Exp Pathol; 1988; 13():240-59. PubMed ID: 3137425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor necrosis factor-alpha in the pathogenesis and treatment of cancer.
    Anderson GM; Nakada MT; DeWitte M
    Curr Opin Pharmacol; 2004 Aug; 4(4):314-20. PubMed ID: 15251122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Biology and clinical pharmacology of tumor necrosis factor alpha].
    Marańda E; Robak T
    Pol Merkur Lekarski; 1997 Jun; 2(12):355-8. PubMed ID: 9424321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Tumor necrosis factor-alpha: a mediator in the pathogenesis of cardiac insufficiency].
    Herrera Garza E; Cubillos Garzón A; Stetson SJ; Cano Niño R; Herrera Flores F; Durand JB; Torre Amione G
    Arch Inst Cardiol Mex; 1999; 69(5):462-8. PubMed ID: 10640210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The effect of recombinant human tumor necrosis factor alpha on malignant tumors in vivo. Physiopathologic basis for clinical oncology].
    Kallinowski F; Schaefer C; Tyler G; Möhle R; Vaupel P
    Arzneimittelforschung; 1989 Mar; 39(3):410-4. PubMed ID: 2757667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-1 and tumor necrosis factor-alpha in the Reed-Sternberg cells of Hodgkin's disease. Correlation with clinical and morphological "inflammatory" features.
    Benharroch D; Prinsloo I; Apte RN; Yermiahu T; Geffen DB; Yanai-Inbar I; Gopas J
    Eur Cytokine Netw; 1996; 7(1):51-7. PubMed ID: 8704095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Tumor necrosis factor-alpha--phase I and phase II clinical trials].
    Chciałowski A; Targowski T; Bajera I; Jahnz-Rózyk K
    Pol Merkur Lekarski; 1997 Jun; 2(12):396-9. PubMed ID: 9424335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High levels of serum interleukin-10 and tumor necrosis factor-alpha are associated with fatality in fulminant hepatitis.
    Nagaki M; Iwai H; Naiki T; Ohnishi H; Muto Y; Moriwaki H
    J Infect Dis; 2000 Oct; 182(4):1103-8. PubMed ID: 10979906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Importance of tumor necrosis factor-alpha in the pathogenesis of heart failure].
    Heberto Herrera Garza E; Herrera Garza JL; Rodríguez González H; Treviño Treviño A; Ibarra Flores M; Torre Amione G
    Rev Esp Cardiol; 2002 Jan; 55(1):61-6. PubMed ID: 11784525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical and pathogenic significance of tumor necrosis factor-alpha in systemic lupus erythematosus].
    Borodin AG; Baranov AA; Kliukvina NG; Abaĭtova NE; Nasonov EL
    Ter Arkh; 2002; 74(5):32-5. PubMed ID: 12087902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biologic therapy for early rheumatoid arthritis: the latest evidence.
    Castro-Rueda H; Kavanaugh A
    Curr Opin Rheumatol; 2008 May; 20(3):314-9. PubMed ID: 18388524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of tumor necrosis factor alpha in hyperthermia-induced apoptosis of human leukemia cells.
    Katschinski DM; Robins HI; Schad M; Frede S; Fandrey J
    Cancer Res; 1999 Jul; 59(14):3404-10. PubMed ID: 10416602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and localization of tumor necrosis factor-alpha and its mRNA in idiopathic pulmonary fibrosis.
    Piguet PF; Ribaux C; Karpuz V; Grau GE; Kapanci Y
    Am J Pathol; 1993 Sep; 143(3):651-5. PubMed ID: 8362967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor necrosis factor: how to improve the antitumor activity and decrease accompanying side effects for therapeutic application.
    Haranaka K
    J Biol Response Mod; 1988 Dec; 7(6):525-34. PubMed ID: 3063778
    [No Abstract]   [Full Text] [Related]  

  • 35. Tumor necrosis factor-alpha in inflammatory myopathies: pathophysiology and therapeutic implications.
    Efthimiou P
    Semin Arthritis Rheum; 2006 Dec; 36(3):168-72. PubMed ID: 16970978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
    Mahmoud RA; El-Gendi HI; Ahmed HH
    Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TNF-alpha in chronic hepatitis C: the smoking gun?
    Kowdley KV
    Am J Gastroenterol; 1999 May; 94(5):1132-5. PubMed ID: 10235183
    [No Abstract]   [Full Text] [Related]  

  • 38. Targeting death receptors in cancer with Apo2L/TRAIL.
    Kelley SK; Ashkenazi A
    Curr Opin Pharmacol; 2004 Aug; 4(4):333-9. PubMed ID: 15251125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor necrosis factor inhibitor therapy for rheumatoid arthritis.
    Naguwa SM
    Ann N Y Acad Sci; 2005 Jun; 1051():709-15. PubMed ID: 16127011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumour necrosis factor-alpha and the failing heart--pathophysiology and therapeutic implications.
    von Haehling S; Jankowska EA; Anker SD
    Basic Res Cardiol; 2004 Jan; 99(1):18-28. PubMed ID: 14685702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.